---

$1.83

-0.0050 ( -0.27% ) 386.6K

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Open	$1.83
Previous Close	$1.83
Volume	386.6K
Market Cap	$77.85M
Day Range	$1.81 - $1.90
52 Week Range	$1.54 - $5.50
Shares Outstanding	42.54M
Change %	-0.27%
Net Change	▼ -0.0050
Insider Ownership	N/A
Exchange	NYSE
Sector	Healthcare
Industry	Biotech
IPO Year	2020
Country
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-11-12	Buy	975610.00	Hoffman Michael B
2025-11-12	Buy	97561.00	Maccecchini Maria-Luisa
2024-07-03	Sale	-29600.00	McCarthy Reid
2024-07-03	Sale	-10000.00	Maccecchini Maria-Luisa
2024-07-03	Sale	-29600.00	Hoffman Michael B
2024-07-03	Sale	-26200.00	Bruck Claudine
2024-07-03	Sale	-26200.00	White Mark K.
2023-11-21	Sale	-164745.00	Hoffman Michael B
2023-11-21	Sale	-2000.00	White Mark K.
2023-11-21	Sale	-41186.00	Maccecchini Maria-Luisa